Liu B - Search Results

1

Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.

Gagnon A, Kim JH, Schorge JO, Ye B, Liu B, Hasselblatt K, Welch WR, Bandera CA, Mok SC. Gagnon A, et al. Among authors: liu b. Clin Cancer Res. 2008 Feb 1;14(3):764-71. doi: 10.1158/1078-0432.CCR-07-0856. Clin Cancer Res. 2008. PMID: 18245537 Free article.

2

Prostate carcinoma tissue proteomics for biomarker discovery.

Zheng Y, Xu Y, Ye B, Lei J, Weinstein MH, O'Leary MP, Richie JP, Mok SC, Liu BC. Zheng Y, et al. Among authors: liu bc. Cancer. 2003 Dec 15;98(12):2576-82. doi: 10.1002/cncr.11849. Cancer. 2003. PMID: 14669276 Free article.

3

Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.

Tang L, Yang J, Ng SK, Rodriguez N, Choi PW, Vitonis A, Wang K, McLachlan GJ, Caiazzo RJ Jr, Liu BC, Welch WR, Cramer DW, Berkowitz RS, Ng SW. Tang L, et al. Eur J Cancer. 2010 Jan;46(1):170-9. doi: 10.1016/j.ejca.2009.10.003. Eur J Cancer. 2010. PMID: 19926475 Free PMC article.

4

Chromatofocusing fractionation and two-dimensional difference gel electrophoresis for low abundance serum proteins.

Qin S, Ferdinand AS, Richie JP, O'Leary MP, Mok SC, Liu BC. Qin S, et al. Proteomics. 2005 Aug;5(12):3183-92. doi: 10.1002/pmic.200401137. Proteomics. 2005. PMID: 16035113

5

CA125 immune complexes in ovarian cancer patients with low CA125 concentrations.

Cramer DW, O'Rourke DJ, Vitonis AF, Matulonis UA, Dijohnson DA, Sluss PM, Crum CP, Liu BC. Cramer DW, et al. Clin Chem. 2010 Dec;56(12):1889-92. doi: 10.1373/clinchem.2010.153122. Epub 2010 Oct 13. Clin Chem. 2010. PMID: 20943848 Free PMC article.

6

The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigens.

Ehrlich JR, Tang L, Caiazzo RJ Jr, Cramer DW, Ng SK, Ng SW, Liu BC. Ehrlich JR, et al. Methods Mol Biol. 2008;441:175-92. doi: 10.1007/978-1-60327-047-2_12. Methods Mol Biol. 2008. PMID: 18370319

7

Proteomics approaches to urologic diseases.

Liu BC, Ehrlich JR. Liu BC, et al. Expert Rev Proteomics. 2006 Jun;3(3):283-96. doi: 10.1586/14789450.3.3.283. Expert Rev Proteomics. 2006. PMID: 16771701 Review.

8

Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.

Qin S, Qiu W, Ehrlich JR, Ferdinand AS, Richie JP, O'leary MP, Lee ML, Liu BC. Qin S, et al. Proteomics. 2006 May;6(10):3199-209. doi: 10.1002/pmic.200500673. Proteomics. 2006. PMID: 16596707

9

Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen.

O'Rourke DJ, DiJohnson DA, Caiazzo RJ Jr, Nelson JC, Ure D, O'Leary MP, Richie JP, Liu BC. O'Rourke DJ, et al. Clin Chim Acta. 2012 Mar 22;413(5-6):561-7. doi: 10.1016/j.cca.2011.11.027. Epub 2011 Nov 29. Clin Chim Acta. 2012. PMID: 22146597 Free PMC article.

10

The 'reverse capture' autoantibody microarray: a native antigen-based platform for autoantibody profiling.

Ehrlich JR, Qin S, Liu BC. Ehrlich JR, et al. Nat Protoc. 2006;1(1):452-60. doi: 10.1038/nprot.2006.66. Nat Protoc. 2006. PMID: 17406268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,605 results

Search Page

Filters